chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient brought back to chemo room for 1st dose of Pfizer BioNTech vaccine. LOT: ER2613  Man Exp: 07/20/2021. Patient appeared anxious about receiving vaccine but was alert and oriented x4 and ambulatory with no other complaints. No previous reactions to vaccinations per patient. Patient received Covid vaccine at 1002, patient started coughing and complaining of chest tightness at 1005 with auditory wheezing. First Epi given at 1005 and O2 was placed on patient via face mask at 15L. 911 was then called. O2 saturations at beginning of reaction in the high 80's and dropping, HR 150's. Unable to obtain blood pressure throughout episode at clinic. IV access attempted and unsuccessful x1 at clinic. Saturations continued to drop into low 70's with no improvement of respiratory symptoms. Decision was made to give second Epi and was given at 1010. Before second attempt to establish IV access EMT arrived. Patient was transferred to stretcher and taken to Ambulance via EMS staff.
I first had chills and a low-grade fever with a migraine. That was around 5 PM that night. At around 9:00 PM I had chills, migraine, bodyaches, burning sensation in my joints, neck pain, and a low-grade fever. I took some Tylenol at around 7 PM. But the pain did not subside and I was able to use the bathroom the next day at around 4 AM and was still in severe pain. That day at around 1 PM I was able to set up and felt 30% better. On day two I am feeling better but I still have minor body aches I do get fatigue while doing light work around the house and no appetite and loss of taste is the newest symptom. I am not 100 percent better but close to it.
Patient received improperly diluted Pfizer covid vaccine. The vaccine was diluted with 1.4ml of sodium chloride instead of the required 1.8ml so it was more concentrated than indicated. No adverse events reported at this time.
12 hours later, in the lower part of my body from the waist down I had aching muscles. it was very pronounced. It continued til 1 pm the next day. I felt like I had the flu. I was cold/had chills. I did not have a fever. I took Tylenol which helped with the achiness.
Chill, tiredness and shakes right after the shot.  There days after I got difficulty to breath at my wake up and lasts around 2 hours
Having a really bad headache last night; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Having a really bad headache last night) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In August 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, the patient experienced HEADACHE (Having a really bad headache last night). The patient was treated with IBUPROFEN on 02-Sep-2021 for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Having a really bad headache last night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided by the reporter.
Vaccine given 02/26/01; presented on 4/2/01 with petechial rash and platelet count 2,000. Dx'd with ITP by Labs and Bone marrow aspiration.
Patient received Janssen shot in March and should not have received first dose of Pfizer vaccine. No adverse side effects were reported by patient - but at this time, second dose is not needed and will not be completed.
Moderate to severe abdominal pain, increasing in severity through Friday and Saturday.  Went to ER Sat and was diagosised with panniculitus
Initial report received from a pharmacist on 15 Jan 2010: This patient was vaccinated with S-OIV FLUVIRIN of an unknown batch number, 0.25 ml on unknown date which was stored at temperatures as low as 34F and 35 F. No adverse event was reported. After an internal review on 21 Jan 2010 for the data received on 15 Jan 2010: A non-significant correction was done about the dosage of the vaccine was 0.5 ml and not as 0.25 ml as previously reported.
Post third vax, this child developed meningitis and bacteremia due to "vax failure."  It was indicated that the pt survived but no additional information is expected.
slight flush; experienced an adrenaline high for 3 days/felt ramped up; Felt queasy; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (slight flush), EUPHORIC MOOD (experienced an adrenaline high for 3 days/felt ramped up) and NAUSEA (Felt queasy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032B21A and 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Multiple sclerosis (Chronic progressive) since February 1983, Drug allergy (Sulfa drugs) since 1980, Environmental allergy (Tree Allergies) since 1983 and Spinal osteoarthritis since 2019. Concomitant products included ETODOLAC for Arthritis, GABAPENTIN and BACLOFEN for Primary progressive multiple sclerosis, COLECALCIFEROL (VITAMIN D 3), PRE & PROBIOTIC and CANNABIDIOL (CBD OIL) for an unknown indication.   On 16-Mar-2021 at 1:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021 at 10:45 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced FLUSHING (slight flush), EUPHORIC MOOD (experienced an adrenaline high for 3 days/felt ramped up) and NAUSEA (Felt queasy). On 14-Apr-2021, NAUSEA (Felt queasy) had resolved. On 17-Apr-2021, EUPHORIC MOOD (experienced an adrenaline high for 3 days/felt ramped up) had resolved. On 28-Apr-2021, FLUSHING (slight flush) had resolved.            The patient experienced as their brain fog cleared, felt ramped up, and was cleaning out closets and boxes.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-May-2021: Follow-up information received on 23-May-2021 included patient's race, height and weight, medical history, concomitant medications, dose 1 details were added. On 31-Jul-2021: additional information Medical history,Spinal arthritis was updated.
She started with upset stomach and sweating that evening. Then the next day she noticed redness all the way around her arm, swelling, pain and hot to the touch. She took anti-inflammatory and used ice packs.
This is a spontaneous report from a contactable physician communicated to a Pfizer sales representative of an unknown age and gender patient.  It was reported that "the patient received all 4 doses of PREVNAR back in 1997-dx with pneumonia with hospitalizations for one month because of the bacterial infections".  The patient was treated with IV penicillin.  It was also reported that the patient "now has Asthma and if the patient needs the booster for PCV 23."  The outcome of the event is unknown.  No other relevant medical history or test results were provided.  This report is lacking information critical for an independent medical assessment.  Clinical evaluation is postponed after receipt of additional information.  Based on the information provided in the case, this individual report would not seem to modify the benefit/risk profile of the suspect product.
Swelling, erythema & heat. Body aches. 1st time ever received vaccine.
At home several hours later patient was found unconscious on the floor of his room. He roused with stimulation, but was confused and unsteady. When EMT got there he had stable vital signs and normal blood sugar, and was returning to baseline. When I spoke with mom a couple hours after that he seemed completely fine, other than a petechial rash around his right eye. There were no witnesses to him losing consciousness, it is unclear if this was syncope, or if he had had a seizure and was post-ictal.
headache for 24 hours starting 8 hours after injection. Fatigue all  day after and day after injection. Fever of 100 for 4-6 hours day after injection.
5-11 year COVID-19 dose administered instead of 6 month to 4-year-old dose. I thought scanned medication would have been a hard stop. I discovered when I went to print immunization record, it had not scanned. Parent notified and RL solution submitted.
I had body ache and fever. My pain was all over, with no cough. I really felt terrible. I had COVID-19 on 02/21/2023, I was given PAXLOVID. Two days after finishing it I was still positive. I finished the medication and the symptoms returned. They were more in the sinuses, and I developed a cough and runny nose. I felt lethargic with no energy. Medical personal instructed me to stay home and mask up. This lasted for about five more days. I am a little horse than usual, but I feel fine now.
Localized edema, erythema, tenderness and pruritis. Lesion approximately 6 inches diameter.
stiff neck within 12 hr-redness-swelling-hot itchy x 24 hr
A rash developed on the back of the right leg.  There was also a white spot at the injection site
Irritability, mood changes, angry outbursts, self injury ideation and urges, suicidal ideation and urges. None of the symptoms were felt before vaccine
01/27/22 presents to ED for "fall". PMHx of "HTN, HLD, COPD on 3L nasal cannula, paroxysmal Afib"
pt recvd flu vax & devel a local react characterized by redness, pain, swelling, & itching on the first day; pt also c/o of a sore throat & malaise;
This case was reported by a other health professional via (Shingrix GSK) interactive digital media and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 1st dose 14th Months ago). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown. Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked did need to resatart series.
C/O stiff neck and headache, aching neck nodes and (L) axillary tenderness since 10/5 seeming to rove today. Symptoms have gotten a little worse: No  lymphadenopathy, 97.2 temp., sl. red throat. This is day 13 post vaccination. 10/12/07 Pt called to report his stiff neck and soreness in the right axillary area had not improved but had not gotten worse. He reports irritable symptom. Discussed resources for him for medical provider - told he should consult a doctor. He reports he called the clinic but it is closed on Fridays. Told him about urgent care hours 12N - 8 PM 7 days a week walk in if he cannot get to his doctor. Received vaccine related symptoms in pt.
No additional AEs reported; GARADASIL 9 given to a 5 year old female; This spontaneous report was received from a nurse and refers to a 5 years old female patient. No information regarding the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant medications was provided.  On 29-JAN-2021, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, prefilled syringe, 0.5 milliliter, lot # 1586749 was confirmed to be valid, expiration date was 13-FEB-2021 (route of administration and anatomical location were not reported) for prophylaxis (product administered to patient of inappropriate age). No additional adverse events was reported. No further information was provided. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1586749; expirationdate: 13-FEB-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
89 year old vaccinated male was admitted initially for respiratory failure from Covid-19 infection. He has tracheostomy and PEG from recent cerebral hemorrhage for which he was treated at another facility. He was in a HCF prior to admission here. He was treated for the infection with Remdesivir and antibiotics for empiric therapy. He also was found to have a DVT in RLE. Since he is not a candidate for anticoagaulation due to recent hemorrhage, IVC filter was placed on 2/25. Family requested placement at a different HCF. He has been accepted at another HCF but has to wait 20 days due to the Covid-19 infection. He will be transferred there today.
This spontaneous report was received from a 64-year-old female patient regarding herself. Current conditions included high blood pressure, allergy to codeine. On 22-OCT-2012 the patient was vaccinated with a single dose of ZOSTAVAX (lot #, expiration date not reported) subcutaneously in her left arm. Concomitant medications included blood pressure medications, sleeping medication and TRAZADOL. Patient stated that on 23-OCT-2012 she got a hard lump, pain, swollen from elbow to wrist, in her left arm where the ZOSTAVAX was given. She described it as warm and with headache, redness, itchy. The redness had subsided but the lump was still there. She would be going to her physician on 15-NOV-2012. No treatment was given for the events. The outcome of rest of the events were unknown at the time of this report. The patient sought medical attention for the events. Additional information has been requested.
Itching on back with no rash noted with face itching that was improved with Benadryl. Pt felt better with no airway issues. was able to be DC home
The patient developed chicken pox about 3 years after receiving the vaccine. Unspecified medical attention was sought. Additional information has been requested.
Low grade temp at about 100.3 degrees; Vomiting; Fatigue; Slowed down; Sore arm; Warmth and pain near the injection; pain near the injection; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Slowed down), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Warmth and pain near the injection), PYREXIA (Low grade temp at about 100.3 degrees) and VOMITING (Vomiting) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Warmth and pain near the injection) and VACCINATION SITE PAIN (pain near the injection). On 12-Jan-2021, the patient experienced ASTHENIA (Slowed down), PYREXIA (Low grade temp at about 100.3 degrees), VOMITING (Vomiting) and FATIGUE (Fatigue). At the time of the report, ASTHENIA (Slowed down), PAIN IN EXTREMITY (Sore arm), VACCINATION SITE WARMTH (Warmth and pain near the injection), PYREXIA (Low grade temp at about 100.3 degrees), VOMITING (Vomiting), FATIGUE (Fatigue) and VACCINATION SITE PAIN (pain near the injection) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, Body temperature: 100.3 (Inconclusive) 100.3.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
"Moderna COVID-19 Vaccine EUA" - I received my first Covid vaccine at 9:30am. By 4:00pm, my left arm was aching. The next day, my arm hurt really bad & a blister rash developed on my left arm from my palm to my arm pit. The next day, the blister rash was killing me & I did not feel well at all. The next day, my head was about to explode. It hurt so bad, I threw up everything I had eaten until all that was left was bile.
TIGHTNESS IN LEFT HAND; PAIN IN LEGS; PAIN IN BOTH KNEES; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (TIGHTNESS IN LEFT HAND), PAIN IN EXTREMITY (PAIN IN LEGS) and ARTHRALGIA (PAIN IN BOTH KNEES) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Psoriatic arthritis and Plaque psoriasis.    Concurrent medical conditions included Psoriatic arthritis and Plaque psoriasis.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced MUSCLE TIGHTNESS (TIGHTNESS IN LEFT HAND), PAIN IN EXTREMITY (PAIN IN LEGS) and ARTHRALGIA (PAIN IN BOTH KNEES). At the time of the report, MUSCLE TIGHTNESS (TIGHTNESS IN LEFT HAND), PAIN IN EXTREMITY (PAIN IN LEGS) and ARTHRALGIA (PAIN IN BOTH KNEES) had not resolved.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  It was unknown if the patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant product use was reported.   No treatment information was provided.  The reporter's causality for the events of tightness in left hand, pain in legs and pain in both knees with Humira (Adalimumab) was reasonable possibility.
28 month old (ex - 30 week preemie) male was seen in pediatric clinic for outpatient evaluation of croup. Examining attending physician described barking cough but no stridor at rest. Given dexamethasone 9 mg and vaccines. Child put to bed "fine". Found dead next morning. Unsuccessful resuscitation.
Patient collapsed to hands and knees a few minutes after vaccination. Did not require medical assistance. Was able to leave on his own afterwards
Patient has reported having an issue with fainting with vaccines in the past.  Approximately 1 minute post vaccine, patient reported feeling dizziness and nausea.  Patient was laid down on the floor with her feet elevated and given a cold compress for the back of her neck and her wrists.   Patient did not lose consciousness but did report dizziness, nausea, and numbness in her hands and fingers.  Patient was able to hold conversation and reported feeling better after about 5 minutes.  Patient was allowed to move to a sitting position and was monitored for any changes.  Patient reported feeling better.   Patient was monitored for an additional 15 minutes and reported feeling normal before she left.
Information has been received from a registered nurse concerning a female patient who on approximately 23-MAY-2012 "Wednesday or Thursday of last week" was vaccinated with a dose of ZOSTAVAX (Merck) (dose, route and lot # not provided). On approximately 25-MAY-2012 "2 days later", the patient was taken to the Emergency Room (ER) because the patient had a waffle sized knot at the injection site and she also had a shingles breakout on her forehead and was hospitalized. She was treated in the ER medicinally for the shingles however no medications were specified that had been used. At the time of the report, the patient's outcome was unknown. Additional information has been requested.
Client's mother, called 6/22/07 reporting that patient cannot turn his head because he says his neck and head hurt. He states his neck is very stiff. Mother states s/s began on 6/21/07. Varicella and #1 Hep A given on 6/20/07. I referred client to PMD. 6/28/07. Mother states s/s resolved in 24 hrs. Did not go to PMD.
Dose 1 Moderna Date:20Feb2021 ,  Dose 2: Moderna Date: 28Mar2021; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 Moderna Date:20Feb2021 ,  Dose 2: Moderna Date: 28Mar2021) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 008B212A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 Moderna Date:20Feb2021 ,  Dose 2: Moderna Date: 28Mar2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Dose 1 Moderna Date:20Feb2021 ,  Dose 2: Moderna Date: 28Mar2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided  It was reported that the Ethnicity was Other   The treatment medication was not reported.   This case was linked to MOD-2022-557722 (Patient Link).
exp aching & soreness for 2wk p/vax;MD prescribed ATB but it just upset pt stomach;
headache; slight tiredness; a sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), FATIGUE (slight tiredness) and VACCINATION SITE PAIN (a sore arm at the injection site) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced HEADACHE (headache), FATIGUE (slight tiredness) and VACCINATION SITE PAIN (a sore arm at the injection site). At the time of the report, HEADACHE (headache), FATIGUE (slight tiredness) and VACCINATION SITE PAIN (a sore arm at the injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications reported by reporter No treatment medications provided by the reporter.     This case was linked to MOD-2022-438856, MOD-2022-438857 (Patient Link).
Patient complains of a rash on shoulder and back with nerve involvement pain and weakness after the ZOSTAVAX vaccine was administered.